Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.spinee.2015.05.001 | DOI Listing |
Radiol Case Rep
February 2025
Department of Psychiatry, Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra 442001, India.
Sacral chordoma is a rare osseous tumor of malignant origin. Remnants of the notochord in the region of sacrum and coccyx is said to be the origin of these tumors. Patients generally have delayed presentation, which is responsible for larger tumor size.
View Article and Find Full Text PDFCureus
October 2024
Neurosurgery, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
Giant cell tumors (GCTs) of bone are classified as intermediate malignant tumors with a significant potential for local infiltration. Despite their benign histopathological appearance, these tumors exhibit extreme local aggression. The sacrum is the most commonly affected spinal region, followed by the lumbar, cervical, and thoracic regions.
View Article and Find Full Text PDFMycopathologia
June 2024
Department of Dermatovenereology, West China Hospital of Sichuan University, Chengdu, China.
Cancer Med
June 2024
Department of Musculoskeletal Tumor, People's Hospital, Peking University, Beijing, China.
Aims: We endeavored to introduce a novel scoring system (Lumbar Functional Index, LFI) capable of evaluating lumbar function in pelvic bone sarcoma patients who underwent surgical resection and spinal pelvic fixation, while simultaneously identifying the incidence, outcomes, and risk factors of lumbar function impairment among these populations.
Patients And Methods: A cohort of 304 primary bone sarcoma patients were recruited. The LFI was created based on the Oswestry Dysfunction Index (ODI) and Japanese Orthopaedic Association (JOA) scores.
Childs Nerv Syst
May 2024
Department of Neurosurgery, The First Hospital of Hebei Medical University, 89# Dong-Gang Road, Hebei Province, Shijiazhuang, 050000, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!